Surface Binding Energy Landscapes Affect Phosphodiesterase Isoform-Specific Inhibitor Selectivity

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Human phosphodiesterase (PDE) proteins are key drug targets, leading to the development of numerous selective PDE inhibitors.
• The conserved nature of catalytic sites across PDE isoforms presents a challenge in understanding inhibitor selectivity.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the high selectivity of a PDE2A inhibitor (BAY60-7550) for its target.
• To explore how inhibitor interactions with PDE surfaces contribute to isoform selectivity.

Main Methods:

• Long-time scale molecular dynamics (MD) simulations were employed.
• The spontaneous association of BAY60-7550 with six PDE isoform catalytic pockets was analyzed.
• Free-energy landscapes of inhibitor-protein interactions were computed.

Main Results:

• Significant differences in free-energy landscapes were observed between PDE isoforms upon interaction with BAY60-7550.
• A favorable low-energy pathway on the PDE2A surface was identified, guiding the inhibitor to its binding site and native conformation.
• Inhibitor interactions with PDE surface residues were found to be crucial for PDE2A selectivity.

Conclusions:

• Inhibitor selectivity for PDE isoforms is influenced by interactions with surface residues, not solely catalytic site binding.
• This finding provides fundamental insights into achieving high PDE isoform-specific inhibitor selectivity.
• The study offers a novel perspective for the rational design of more selective PDE inhibitors.